FDA Cracks Down on Amazon and Global Drug Manufacturers Over Unapproved Products and Serious CGMP Violations

FDA Issues Multiple Warning Letters Targeting Online Retailers and Pharmaceutical Manufacturers The FDA has upped its game with increased enforcement action by releasing a number of warning letters to online retailers and drug manufacturers for their non-compliance with CGMPs and Read More …

The V-Model in Computer Systems Validation: Structural Mechanics, Differences, and Evolving into Computer Software Assurance

Computer Systems Validation (CSV) acts as the main regulatory control framework for guaranteeing that computerized systems utilized within GxP-regulated life science industries such as the pharmaceutical, biotech, and medical device industries function in a consistent, reliable manner that fully complies Read More …

Understanding LIMS: How to Optimize Your Laboratory Workflow

Understanding LIMS Infographic for PharmaJobAid In today’s pharmaceutical and laboratory industries, digital transformation is becoming essential for maintaining compliance, improving efficiency, and ensuring data integrity. A Laboratory Information Management System (LIMS) is one of the most important technologies helping laboratories Read More …

A Comprehensive Analysis of ICH Q9(R1) and the Evolving Standards of Quality Risk Management

The formal adoption of the ICH Q9(R1) guideline in January 2023 represents a pivotal advancement in the global harmonization of pharmaceutical quality standards, addressing nearly two decades of implementation experience and evolving industrial complexities. Originally introduced in 2005, the ICH Read More …

Pharmaceutical R&D and Drug Development Lifecycle: From Discovery to Commercialization

Introduction Every year, the pharmaceutical industry in the United States develops several new pharmaceuticals that give significant medical benefits. Many of these drugs are expensive, contributing to increased healthcare expenses for both the private and federal governments. Policymakers have discussed Read More …